Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2526)
  3. Review (121)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5696)
  2. Department of Medicine (5686)
  3. GSK Faculty (1659)
  4. Human Oncology and Pathogenesis Program (1158)
  5. Department of Pathology and Laboratory Medicine (1130)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (786)
  4. Dean Bajorin (664)
  5. Michael Morris (588)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (204)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (690)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (304)

More Publishers

Results (5696)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-line treatment and prognostic factors of metastatic bladder cancer for platinum-eligible patients
    Journal Article

    Abida, W.; Bajorin, D. F.; Rosenberg, J. E.
    Hematology/Oncology Clinics of North America (2015)

    Fulltext@MSK | Save
  • Cancer of the prostate
    Book Section

    Scher, H. I.; Scardino, P. T.; Zelefsky, M. J.
    In DeVita, V. T. Jr; Lawrence, T. S.; Rosenberg, S. A. (Eds.) DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 10th ed (2015)

    Fulltext@MSK | Save
  • Association between geographic access and receipt of radiation therapy
    Meeting Abstract

    Lin, C. C.; Bruinooge, S.; Kirkwood, K.; Hershman, D. L.; Jemal, A.; Yu, J. B.; Guadagnolo, B. A.; Hopkins, S.; Goldstein, M.; Bajorin, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • Deleterious alterations in DNA damage response genes are associated with improved outcome in muscle-invasive bladder cancer patients treated with radiation-based bladder preservation
    Meeting Abstract

    Desai, N. B.; Iyer, G. I.; Cha, E. K.; Scott, S. N.; Hreiki, J.; Sfakianos, J.; Bagrodia, A.; Bochner, B. H.; Rosenberg, J. E.; Bajorin, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • Immunotherapeutic approaches in prostate cancer: Combinations and clinical integration
    Journal Article

    Slovin, S. F.
    American Society of Clinical Oncology Educational Book (2015)

    Fulltext@MSK | Save
  • Examining the genomic differences between upper and lower tract urothelial carcinomas
    Meeting Abstract

    Scott, S. N.; Sfakianos, J. P.; Cha, E. K.; Iyer, G.; Zabor, E. C.; Kim, P. H.; Hakimi, A. A.; Ostrovnaya, I.; Ramirez, R.; Hanrahan, A. J.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Targeting EZH2 in neuroendocrine prostate cancer
    Meeting Abstract

    Puca, L.; Gao, D.; Kossai, M.; Marotz, C.; Mosquera, J. M.; MacDonald, T. Y.; Park, K.; Rao, R.; Sboner, A.; Chen, Y.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Androgen receptor (AR) mutations in patients (pts) with castration-resistant prostate cancer (CRPC) with and without prior abiraterone acetate (AA) treatment
    Meeting Abstract

    Rathkopf, D. E.; Smith, M. R.; Antonarakis, E. S.; Ryan, C. J.; Berry, W. R.; Shore, N. D.; Liu, G.; Higano, C.; Alumkal, J. J.; Hauke, R.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase I of oral BKM120 or BYL719 and olaparib for high-grade serous ovarian cancer or triple-negative breast cancer: Final results of the BKM120 plus olaparib cohort
    Meeting Abstract

    Matulonis, U. A.; Wulf, G.; Barry, W.; Birrer, M.; Westin, S.; Spagnoletti, T.; Bell-McGuinn, K.; Obermayer, E.; Whalen, C.; Aghajanian, C.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • SU2C Phase Ib study of the PI3K-alpha inhibitor BYL719 (alpelisib) with letrozole in ER+/HER2-metastatic breast cancer
    Meeting Abstract

    Mayer, I. A.; Abramson, V.; Balko, J.; Sanders, M.; Juric, D.; Solit, D.; Li, Y. S.; Cantley, L.; Winer, E.; Arteaga, C.
    Cancer Research (2015)

    Fulltext@MSK | Save